Clinical Trial Update: Triple Negative Breast Cancer Biomarker Study

View source ↗

Summary

A completed biomarker-focused clinical trial for metastatic triple-negative breast cancer sponsored by US Oncology Research.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: US Oncology Research | Conditions: Metastatic Breast Cancer, Triple Negative Breast Cancer | Status: COMPLETED